The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127787501 12778750 1 I 20160919 20160926 20160926 EXP JP-BAUSCH-BL-2016-023150 BAUSCH AND LOMB MORICHIKA D, SATO-HISAMOTO A, HOTTA K, TAKATA K, IWAKI N, IWAKI N, UCHIDA K, MINAMI D, KUBO T, TANIMOTO M, KIURA K. FATAL CANDIDA SEPTIC SHOCK DURING SYSTEMIC CHEMOTHERAPY IN LUNG CANCER PATIENT RECEIVING CORTICOSTEROID REPLACEMENT THERAPY FOR HYPOPITUITARISM: A CASE REPORT. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2014;44(5):501-505. 72.00 YR M Y 0.00000 20160926 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127787501 12778750 1 PS HYDROCORTISONE. HYDROCORTISONE 1 Unknown D 18514 3.3 MG
127787501 12778750 2 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown D 40069
127787501 12778750 3 SS CARBOPLATIN. CARBOPLATIN 1 Unknown CBDCA: AREA UNDER THE CURVE OF 5 ON DAY 1 D 0
127787501 12778750 4 SS CARBOPLATIN. CARBOPLATIN 1 Unknown (CBDCA AUC OF 3.5)?2ND CYCLE OF CHEMOTHERAPY DOSE WAS REDUCED D 0
127787501 12778750 5 SS PACLITAXEL. PACLITAXEL 1 Unknown ON DAY 1 D 0 200 MG/M**2
127787501 12778750 6 SS PACLITAXEL. PACLITAXEL 1 Unknown 2ND CYCLE OF CHEMOTHERAPY DOSE WAS REDUCED D 0 141 MG/M**2

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127787501 12778750 1 Hypopituitarism
127787501 12778750 2 Prophylaxis
127787501 12778750 3 Chemotherapy
127787501 12778750 5 Chemotherapy

Outcome of event

Event ID CASEID OUTC COD
127787501 12778750 DE
127787501 12778750 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127787501 12778750 Abdominal distension
127787501 12778750 Febrile neutropenia
127787501 12778750 Lung squamous cell carcinoma stage III
127787501 12778750 Pancytopenia
127787501 12778750 Septic shock
127787501 12778750 Systemic candida

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found